Last reviewed · How we verify
NCT05211752: e-VOG(YA)
Eye Movements Recording Using a Mobile : Comparison to Standard Video-oculography in Young Athletes
trial testing eVOG (Mobile VideoOculoGraphy) in Healthy in 46 participants. Completed in 22 February 2022.
22 February 2022
Quick facts
| Lead sponsor | Association de Recherche Bibliographique pour les Neurosciences |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 46 |
| Start date | 18 January 2022 |
| Primary completion | 22 February 2022 |
| Estimated completion | 22 February 2022 |
| Sites | 1 location across Monaco |
Drugs / interventions tested
- eVOG (Mobile VideoOculoGraphy)
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Association de Recherche Bibliographique pour les Neurosciences
Who can join
Adults 15 to 20, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to compare measurements obtained through the e-VOG application (mobile application, usable on smartphones or tablets, to measure eye movements) with measurements from the standard video-oculography device (Eye-Tracker®T2), in young athletes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Associations between frailty, biomarkers of cerebral pathology, cognitive and neuropsychiatric symptoms: a memory clinic study.
Gilles V, Flaus A, Teillac A, Verny M, et al · · 2026 · PMID 41880327 · DOI 10.1016/j.tjfa.2026.100148
Verify or expand the search:
- PubMed search for NCT05211752
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of eVOG (Mobile VideoOculoGraphy)
Trials testing the same drug.
- NCT05385601 — Eye Movements Recording Using a Smartphone: Comparison to Standard Video-oculography and Correlation to Imaging Data in · completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Association de Recherche Bibliographique pour les Neurosciences trials
Trials by the same sponsor.
- NCT05385601 — Eye Movements Recording Using a Smartphone: Comparison to Standard Video-oculography and Correlation to Imaging Data in · completed
- NCT05267028 — Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease · completed
- NCT05254873 — Long-term Follow-up of Patients Included in the EYE-TAR(MA) Study. · completed
- NCT04730167 — The Monaco Initiative for Concussion in Motorsport Pilots · completed
- NCT04702763 — Eye Movements Recording Using a Smartphone: Comparison to Standard Video-oculography in Patients With Multiple Sclerosis · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05211752 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Association de Recherche Bibliographique pour les Neurosciences
- Last refreshed: 18 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05211752.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing